Fortress Biotech, Inc. (FBIO)
3.72
+0.24
(+6.90%)
USD |
NASDAQ |
Jan 16, 16:00
3.69
-0.03
(-0.81%)
After-Hours: 20:00
Fortress Biotech SG&A Expense (TTM): 108.70M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Journey Medical Corp. | 44.56M |
| Ultragenyx Pharmaceutical, Inc. | 343.56M |
| Axsome Therapeutics, Inc. | 514.57M |
| Apellis Pharmaceuticals, Inc. | 524.64M |
| Absci Corp. | 35.27M |